Ameriprise Financial Inc. Has $8.48 Million Position in CorVel Co. (NASDAQ:CRVL)

Ameriprise Financial Inc. boosted its position in CorVel Co. (NASDAQ:CRVL) by 182.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 76,228 shares of the business services provider’s stock after purchasing an additional 49,206 shares during the period. Ameriprise Financial Inc. owned 0.15% of CorVel worth $8,481,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Algert Global LLC increased its holdings in CorVel by 202.5% in the 4th quarter. Algert Global LLC now owns 97,649 shares of the business services provider’s stock worth $10,864,000 after purchasing an additional 65,365 shares in the last quarter. LGT Financial Advisors LLC grew its position in shares of CorVel by 200.0% in the 4th quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock valued at $28,000 after buying an additional 170 shares during the last quarter. Comerica Bank grew its position in shares of CorVel by 197.6% in the 4th quarter. Comerica Bank now owns 25,623 shares of the business services provider’s stock valued at $2,851,000 after buying an additional 17,013 shares during the last quarter. Voleon Capital Management LP bought a new stake in shares of CorVel in the 4th quarter valued at about $846,000. Finally, Northern Trust Corp grew its position in shares of CorVel by 210.8% in the 4th quarter. Northern Trust Corp now owns 379,743 shares of the business services provider’s stock valued at $42,250,000 after buying an additional 257,561 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

Insider Buying and Selling at CorVel

In related news, Director Jeffrey J. Michael sold 16,523 shares of the company’s stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the sale, the director now owns 551,787 shares in the company, valued at $64,553,561.13. This represents a 2.91% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 47.57% of the company’s stock.

CorVel Trading Down 0.6%

NASDAQ CRVL opened at $113.67 on Wednesday. The business’s 50-day moving average price is $111.61 and its two-hundred day moving average price is $116.64. CorVel Co. has a 12 month low of $76.53 and a 12 month high of $128.61. The firm has a market capitalization of $5.84 billion, a PE ratio of 66.87 and a beta of 1.10.

Analyst Ratings Changes

Separately, StockNews.com upgraded CorVel from a “hold” rating to a “buy” rating in a research report on Friday, April 18th.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.